Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Management of Fecaloma (Fecal Impaction)

Immediate Management Algorithm

  • The American Society of Clinical Oncology recommends manual disimpaction through digital fragmentation and extraction of the stool, followed immediately by implementation of a maintenance bowel regimen to prevent recurrence 1, 2, 3
  • Before proceeding with any intervention, exclude suspected bowel perforation or active gastrointestinal bleeding, neutropenia or thrombocytopenia, recent colorectal or gynecological surgery, recent anal or rectal trauma, paralytic ileus or intestinal obstruction, severe colitis, abdominal inflammation/infection, or toxic megacolon, and recent pelvic radiotherapy 1, 2, 4
  • Perform digital fragmentation and extraction of the fecaloma as the primary intervention when no contraindications exist, and ensure patient privacy, comfort, and appropriate positioning during the procedure 1, 2, 3, 5, 6

Post-Disimpaction Maintenance

  • Implement environmental modifications, such as ensuring privacy and comfort for normal defecation, providing proper positioning with a small footstool, and ensuring toilet access, especially for patients with decreased mobility 1, 2, 3, 4, 5
  • Increase fluid intake, activity, and mobility within patient limits, and consider abdominal massage, which has evidence for efficacy particularly in patients with neurogenic problems 1, 2, 3, 4, 5
  • Use first-line laxative options, such as polyethylene glycol (PEG) 17g daily, lactulose, or magnesium/sulfate salts, and avoid bulk laxatives like psyllium in non-ambulatory patients with low fluid intake 1, 2, 3, 4, 5, 6

Special Populations

  • Individualize laxatives based on cardiac and renal comorbidities, drug interactions, and adverse effects in elderly patients, and monitor closely if concurrent diuretics or cardiac glycosides prescribed 1, 2, 4, 5
  • All patients on opioid analgesics should receive prophylactic laxatives, unless contraindicated by pre-existing diarrhea, and consider peripherally acting mu-opioid receptor antagonists (PAMORAs) like methylnaltrexone for unresolved cases 1, 2, 3, 5